Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study.  American Journal of Kidney Diseases.  80:174-185.e1. 2022
2022 Sequential Stem Cell-Kidney Transplantation in Schimke Immuno-osseous Dysplasia.  New England Journal of Medicine.  386:2295-2302. 2022
2021 Conversion to permanent vascular access is associated with improved markers of hemodialysis efficacy in children: Pediatric nephrology research consortium study.  Clinical Nephrology.  96:270-280. 2021
2021 Late first acute rejection in pediatric kidney transplantation: A North American Pediatric Renal Trials and Collaborative Studies special study.  Pediatric Transplantation.  25. 2021
2021 Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.  Pediatric Nephrology.  36:1233-1244. 2021
2020 Predictors of time to first cannulation for arteriovenous fistula in pediatric hemodialysis patients: Midwest Pediatric Nephrology Consortium study.  Pediatric Nephrology.  35:287-295. 2020
2019 Kidney support in children using an ultrafiltration device: A multicenter, retrospective study.  Clinical Journal of the American Society of Nephrology.  14:1432-1440. 2019
2019 Correction to: Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients (Pediatric Nephrology, (2019), 34, 2, (329-339), 10.1007/s00467-018-4082-4).  Pediatric Nephrology.  34:1483-1484. 2019
2019 Predictors of patency for arteriovenous fistulae and grafts in pediatric hemodialysis patients.  Pediatric Nephrology.  34:329-339. 2019
2018 Neutral pH and low–glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis.  Kidney International.  94:419-429. 2018
2018 Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease.  Pediatric Nephrology.  33:325-333. 2018
2017 Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.  Pediatric Nephrology.  32:743-751. 2017
2016 Smaller circuits for smaller patients: improving renal support therapy with Aquadex™.  Pediatric Nephrology.  31:853-860. 2016
2015 Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.  Clinical Journal of the American Society of Nephrology.  10:571-577. 2015
2014 Expanding the phenotype of proteinuria in Dent disease. A case series.  Pediatric Nephrology.  29:2051-2054. 2014
2014 Uric acid and the kidney.  Pediatric Nephrology.  29:999-1008. 2014
2012 An open-label study to evaluate a single-dose of cinacalcet in pediatric dialysis subjects.  Pediatric Nephrology.  27:1953-1959. 2012
2008 IgA Nephropathy in children and adults: Comparison of histologic features and clinical outcomes.  Nephrology Dialysis Transplantation.  23:2537-2545. 2008
2006 Sodium modeling attenuates rises in whole-blood viscosity during chronic hemodialysis in children with large inter-dialytic weight gain.  Pediatric Nephrology.  21:1179-1184. 2006
2003 Stages of status epilepticus in the developing brain..  Epilepsy Research.  55:9-19. 2003

Principal Investigator On

  • Chronic Kidney Disease in Children  awarded by CHILDREN'S MERCY HOSPITAL
  • Chronic Kidney Disease in Children (CKiD III)  awarded by CHILDREN'S MERCY HOSPITAL
  • Chronic Kidney Disease in Children CKID IV  awarded by CHILDREN'S MERCY HOSPITAL
  • International Pediatric Peritoneal Biopsy Study in Children  awarded by UNIVERSITY OF HEIDELBERG
  • NAPRTCS Registry of Children Receiving Renal Allografts, Dialysis, or Treatment for Chronic Renal Insufficiency  awarded by NORTH AMERICAN PEDIATRIC RENAL TRANSPLANT TRIALS AND COLLABORATIVE STUDY
  • Private Grant  awarded by ABBVIE INC
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by AMGEN, INC.^
  • Private Grant  awarded by Genzyme Corporation
  • Private Grant  awarded by ABBVIE INC
  • Private Grant  awarded by ROCKWELL MEDICAL, INC.
  • Private Grant  awarded by VIFOR
  • Private Grant  awarded by Sanofi US Services Inc
  • Private Grant  awarded by Genentech
  • Private Grant  awarded by ASTRAZENECA PHARMACEUTICALS LP
  • Private Grant  awarded by KERYX BIOPHARMACEUTICALS, INC. - NEW
  • Randomized Intervention for Children with Vesicoureteral Reflux  awarded by Wayne State University
  • Reaching Equity for Adults and Chldren in Transplant (REACH-TRANSPLANT)  awarded by CHILDREN'S MERCY HOSPITAL
  • The Child-Centered Outcomes in Practice and Research (COPR) Center of Excellence: Strengthing the Clinical Validity Evidence Base for PROMIS Measures in Chronically Ill Children  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA)

    • Investigator On

  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL
  • Kidney Undergraduate Research Experience (KURE)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS
  • NGAL Usage In Determining AKI Risk in Critically Ill Children (GUIDANCE)  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI)
  • Novel Therapies for Chronic Allograft Dysfunction in Children  awarded by CHILDREN'S HOSPITAL (BOSTON)
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION
  • Private Grant  awarded by RETROPHIN, INC.
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Private Grant  awarded by OCTAPHARMA - NEW
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC.
  • Reaching Equity for Adults and CHildren in Transplant (REACH-TRANSPLANT  awarded by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
  • The Genetic Contribution to Drug Induced Renal lnjury:The Drug Induced Renal Injury Consortium (DIRECT)  awarded by INTERNATIONAL SAE CONSORTIOUM, LTD
  • ULTRA-PEDS: Ultrafiltration Therapy Registry using Aquadex –Peds  awarded by ACUTE KIDNEY INJURY CRITICAL CARE REGISTRY FOUNDATION
  • Viral Triggers of Alioimmunity and Autoimmunity in Pediatric Lung Transplantation  awarded by Washington University

    • Education And Training

  • American University of Beirut Medical Center, Internship
  • American University of Beirut Medical Center, Residency
  • Cook County Hospital, Residency
  • Children's Memorial Hospital, Postdoctoral Fellowship
  • University of Texas Southwestern Medical Center, Postdoctoral Fellowship
  • Doctor of Medicine, 2008

    • Full Name

  • Sahar Fathallah-Shaykh